Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023923

Director bought 1,700 shares at $5.85 ($9,945)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bronstein Ben Director 2019-09-17 Purchase +1,700 $5.85 $9,945 18,644 D
Open-market purchases · 1,700 sh · avg $5.85 · $9,945
Loading xslF345X03/doc4.xml…